Figure 2From: Experience of safety monitoring in the context of a prospective observational study of artemether-lumefantrine in rural Tanzania: lessons learned for pharmacovigilance reportingReporting channels for serious adverse events (SAE). IHDSS, Ifakara Health Demographic Surveillance System; TFDA, Tanzanian Food and Drugs Authority; HH, Household; HF, Health Facility; SAS, Satisfaction/Adherence Survey.Back to article page